However, PD-L1 regulation in melanoma cells is exceedingly complex and PD-L1 expression may be driven by tumor-cell intrinsic mechanisms in a proportion of patients who exhibit or develop resistance to anti-PD-1 monotherapy [8,24]. The gene discussed is CD274; the disease is neoplasm.